{"nctId":"NCT04834375","briefTitle":"Randomized Open Investigation Determining Steroid Dose","startDateStruct":{"date":"2021-03-19","type":"ACTUAL"},"conditions":["Covid19"],"count":142,"armGroups":[{"label":"Standard dexamethasone dose","type":"NO_INTERVENTION","interventionNames":[]},{"label":"Weight-based dexamethasone dose","type":"EXPERIMENTAL","interventionNames":["Drug: Weight-based dexamethasone dose"]}],"interventions":[{"name":"Weight-based dexamethasone dose","otherNames":["Higher dexamethasone dose"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Adults greater or equal than 18 years old\n* COVID-19 infection confirmed by positive PCR test\n* Hypoxemia defined by an oxygen saturation \\< 94% or the need for supplemental oxygen\n\nExclusion Criteria:\n\n* Corticosteroid use for \\> 48h within the past 15 days prior to enrollment\n* Use of steroids with doses higher than the equivalent to dexamethasone 6 mg\n* Use of immunosuppressive drugs\n* Pregnant women\n* Chronic oxygen use\n* Known history of dexamethasone allergy\n* DNR / DNI\n* Patient or proxy cannot consent","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"All Cause Mortality at 28 Days","description":"All cause mortality at 28 days.\n\nComment: Primary outcome was all cause mortality at 28 days but the patients were followed until end of admission for the final disposition (death or discharge) which accounts for the differences in the primary outcome of mortality at 28 days and the total number of deaths at discharge","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15","spread":null},{"groupId":"OG001","value":"12","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Admitted to the ICU","description":"Number of participants that required admission to the ICU","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"27","spread":null},{"groupId":"OG001","value":"12","spread":null}]}]}]},{"type":"SECONDARY","title":"Days of Stay in the Intensive Care Unit","description":"ICU length of stay","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15.33","spread":"11.28"},{"groupId":"OG001","value":"11.33","spread":"8.85"}]}]}]},{"type":"SECONDARY","title":"Days of Hospitalization","description":"Duration of hospitalization","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14.83","spread":"17"},{"groupId":"OG001","value":"11.56","spread":"8.88"}]}]}]},{"type":"SECONDARY","title":"Number of Participants That Required Higher Levels of Oxygen Supplementation","description":"Venturi mask, Non-rebreather mask, High-flow nasal cannula, Non-invasive ventilation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"32","spread":null},{"groupId":"OG001","value":"31","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants That Required Invasive Mechanical Ventilation","description":"Escalation to invasive mechanical ventilation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19","spread":null},{"groupId":"OG001","value":"10","spread":null}]}]}]},{"type":"SECONDARY","title":"Duration of Invasive Mechanical Ventilation","description":"Total days requiring invasive mechanical ventilation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19.95","spread":"16.14"},{"groupId":"OG001","value":"10.90","spread":"8.88"}]}]}]},{"type":"SECONDARY","title":"Number of Participants That Required ECMO","description":"Refractory hypoxemia requiring ECMO","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants That Required Tracheostomy","description":"Need for tracheostomy","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants That Developed Secondary Bacterial or Fungal Infections","description":"Culture positive evidence of secondary bacterial or fungal infections","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19","spread":null},{"groupId":"OG001","value":"9","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants That Developed Clinically Significant Hyperglycemia","description":"Defined as need for insulin drip or ICU admission to control hyperglycemia","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants That Required Oxygen Supplementation a Discharge From the Hospital","description":"Need for oxygen supplementation at hospital discharge\n\nComment: Corrected total number of discharged patients alive to 55 in the \"Standard Dexamethasone Dose\" Arm.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"25","spread":null},{"groupId":"OG001","value":"27","spread":null}]}]}]},{"type":"SECONDARY","title":"Subjective Symptoms at 28 Days","description":"Subjective symptoms questionnaire at 28 days","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"33","spread":null},{"groupId":"OG001","value":"44","spread":null}]},{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Disposition Upon Discharge","description":"Home, home with physical therapy, other (skilled nursing facility, long-term acute care facility, long-term care facility / nursing home, acute rehabilitation facility, hospice care), expired","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"40","spread":null},{"groupId":"OG001","value":"42","spread":null}]},{"measurements":[{"groupId":"OG000","value":"10","spread":null},{"groupId":"OG001","value":"11","spread":null}]},{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"5","spread":null}]},{"measurements":[{"groupId":"OG000","value":"17","spread":null},{"groupId":"OG001","value":"12","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":72},"commonTop":["Secondary bacterial or fungal infections","Clinically significant hyperglycemia"]}}}